Position
Renaissance Technologies in Bioventus Inc.
Back to the book · All holders of BVS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $151.7K$9.13 → $9.44
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 615.1K | $4.58M | — | — | — | 0.0% |
| Q1 2026 | 489.5K | $4.47M | $9.13 | $827.2K | −$934.8K | 0.0% |
| Q2 2026 | 736K | $6.95M | $9.44 | $151.7K | $2.33M | 0.0% |